Exactech to fund more than $100,000 in research and residency enhancement grants through OREF's CDP

Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has committed more than $100,000 to fund research and residency enhancement grants and contribute to post-graduate fellowship grants through OREF’s Clinician Development Program (CDP). Exactech has directed its support for fellowship grants to the areas of adult reconstruction, foot and ankle, and shoulder and elbow.

“In addition to their financial support of OREF Clinician Development  Program  grants, we value Exactech’s perspective as an entrepreneurial organization committed to innovation and excellence. We appreciate the commitment of Dr. Bill Petty, CEO, and his executive team for their continued support of research and education within orthopaedic surgery.”

An OREF Corporate Associate since 2001, Exactech’s support for OREF’s CDP affirms its commitment to quality of orthopaedic care, quality of life, and integrity in all its dealings. OREF’s Clinician Development Program is an independent grant-making system free of donor bias that facilitates industry support for orthopaedic education and research while maintaining compliance with best practices. The program was reviewed and approved by three U.S. Department of Justice monitors assigned to device manufacturers by federal mandate.

Exactech President David Petty said, “Founded 25 years ago by an orthopaedic surgeon and biomedical engineer involved in academic medicine, Exactech has a unique perspective on patient care and orthopaedic innovation. We are pleased to continue our partnership with OREF. Supporting the clinical learning for new orthopaedic surgeons is an important investment in improving the outcomes for tomorrow’s patients.”

"We are pleased to enter into an expanded partnership with Exactech, a long-standing OREF Corporate Associate," said William P. Cooney III, OREF board chair.

“In addition to their financial support of OREF Clinician Development  Program  grants, we value Exactech’s perspective as an entrepreneurial organization committed to innovation and excellence. We appreciate the commitment of Dr. Bill Petty, CEO, and his executive team for their continued support of research and education within orthopaedic surgery.”

Source: Exactech Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose